Suppr超能文献

拉贝洛尔在全科医疗中的应用:综述

Labetalol in general practice: a review.

作者信息

Kane J A

出版信息

Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):59S-63S. doi: 10.1111/j.1365-2125.1982.tb01890.x.

Abstract

1 The results of the treatment of 8573 hypertensive patients with labetalol in general practice, for periods between 1 month and 5 yr, are reviewed. 2 The data reviewed were obtained from the published literature together with our own published (Kane et al., 1976; Kane et al., 1979) and more recent (unpublished) work. 3 Between 60% and 80% of severe (diastolic blood pressure greater than 120 mmHg) and previously uncontrolled hypertensives responded satisfactorily to the drug, as did up to 88% of mild to moderate hypertensives. 4 The anti-hypertensive effect of labetalol was not dependent on the frequency of administration, twice and three times daily treatment regimes being equally effective. 5 The withdrawal rate attributable to side-effects was between 6% and 13%. Tiredness, dizziness, headache and upper gastro-intestinal symptoms were the four principal side-effects, but they were usually transient when labetalol treatment was continued. 6 No drug interactions or adverse haematological or biochemical changes were seen.

摘要
  1. 回顾了8573例高血压患者在全科医疗中使用拉贝洛尔治疗1个月至5年的结果。2. 所回顾的数据来自已发表的文献以及我们自己已发表的(凯恩等人,1976年;凯恩等人,1979年)和最近的(未发表的)研究。3. 60%至80%的重度(舒张压大于120毫米汞柱)且先前未得到控制的高血压患者对该药物反应良好,轻度至中度高血压患者中这一比例高达88%。4. 拉贝洛尔的降压效果不取决于给药频率,每日两次和三次的治疗方案效果相同。5. 因副作用导致的停药率在6%至13%之间。疲倦、头晕、头痛和上消化道症状是四种主要副作用,但在继续使用拉贝洛尔治疗时通常是短暂的。6. 未观察到药物相互作用或不良血液学或生化变化。

相似文献

1
Labetalol in general practice: a review.拉贝洛尔在全科医疗中的应用:综述
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):59S-63S. doi: 10.1111/j.1365-2125.1982.tb01890.x.
7
Labetalol.拉贝洛尔
Drug Intell Clin Pharm. 1983 Oct;17(10):704-12.

本文引用的文献

3
Experience with labetalol in essential hypertension.拉贝洛尔治疗原发性高血压的经验。
Curr Med Res Opin. 1980;6(6):407-15. doi: 10.1185/03007998009109460.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验